Sarah Wood, OD
Optometrist · Derry, NHNPI 1598847907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 176 payments — averaging $29.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oyster Point Pharma, Inc.$855
- Alcon$827
- Optos, Inc.$501
- Bausch & Lomb Americas Inc.$398
- AbbVie$360
- Amgen$358
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,01396%
- Entertainment$2054%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oyster Point Pharma, Inc. | 37 | $855 |
| Alcon | 21 | $827 |
| Optos, Inc. | 2 | $501 |
| Bausch & Lomb Americas Inc. | 15 | $398 |
| AbbVie(2 entities) | 12 | $360 |
| Amgen(2 entities) | 7 | $358 |
| Sun Pharmaceutical Industries Inc. | 21 | $342 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $280 |
| Novartis | 9 | $201 |
| Rxsight Inc | 3 | $188 |
| Johnson & Johnson Vision Care, Inc. | 7 | $167 |
| Coopervision Inc. | 3 | $131 |
| Lombart Brothers, Inc. | 2 | $114 |
| Aerie Pharmaceuticals, Inc. | 4 | $78 |
| Glaukos Corporation | 2 | $70 |
| ANI Pharmaceuticals, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Sight Sciences, Inc. | 2 | $43 |
| Thea Pharma Inc. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
| Dompe US, Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $20 |
| ABB Con-cise Optical Group LLC | 1 | $16 |
| LSI Solutions Inc | 1 | $14 |
| Alimera Sciences, Inc. | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANORAMIC OPHTHALMOSCOPE$1,001
- OCT OPHTHALMOSCOPE$706
- NFC-700$501
- TEPEZZA$247
- Clareon$202
- RXSIGHT CONTACT LENS$150
- RXSIGHT INJECTOR CARTRIDGE$150
- RXSIGHT INJECTOR HANDPIECE$150
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$150
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$150
- LUMIGAN$122
- Rocklatan$112
- Rhopressa$112
- TRYPTYR$111
- MIEBO$101
How this compares
$5,218 in reported general payments places this provider in the 95th percentile of 235 optometrist providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 22 | $40,889 |
| XiidraLifitegrast | 30 | $23,832 |
| MieboPerfluorohexyloctane/Pf | 12 | $15,536 |
| TyrvayaVarenicline Tartrate | 11 | $11,504 |
| LumiganBimatoprost | 14 | $5,428 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 11 | $2,232 |
| Latanoprost | 135 | $1,197 |
| Prednisolone Acetate | 19 | $555 |
| Timolol Maleate | 42 | $271 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 15 | $144 |
| Dorzolamide Hcl | 13 | $87 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $398 | $39,36842 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $855 | $11,50411 claims |
| AbbVieLumigan | $360 | $5,42814 claims |
| AlconSimbrinza | $827 | $2,23211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 235 optometrist providers in New Hampshire.
Other optometrist in Derry
- Diane NelsonDerry$3K
- John OblockDerry$3K
- Nicole LeoDerry$2K
- Keith EmeryDerry$2K
- Brandon NguyenDerry$2K
- Dorothy HitchmothNew London$225K
- Lauren McLoughlinPortsmouth$138K
- Debra Poulin-BelairBarrington$55K
- Kelly MacdonaldNashua$6K
- Sarah HudsonPortsmouth$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.